Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Novartis
Farmers Insurance
Fuji
McKesson
Express Scripts
Julphar
UBS
Accenture
Boehringer Ingelheim

Generated: February 18, 2018

DrugPatentWatch Database Preview

DIAPID Drug Profile

« Back to Dashboard

When do Diapid patents expire, and when can generic versions of Diapid launch?

Diapid is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in DIAPID is lypressin. Additional details are available on the lypressin profile page.
Drug patent expirations by year for DIAPID
Medical Subject Heading (MeSH) Categories for DIAPID

US Patents and Regulatory Information for DIAPID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis DIAPID lypressin SOLUTION;NASAL 016755-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
QuintilesIMS
Mallinckrodt
US Department of Justice
Baxter
Boehringer Ingelheim
Queensland Health
Moodys
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot